关注
Ayşegül Aksu
Ayşegül Aksu
İzmir Atatürk Eğitim ve Araştırma Hastanesi
在 ikc.edu.tr 的电子邮件经过验证
标题
引用次数
年份
Baseline Ga-68 PSMA PET-Derived Primary Tumor Parameters in Patients with Prostate Cancer and Their Association with Clinical Risk Stratification and Clinicopathologic Features
ÖV Topuz, A Aksu
World Journal of Nuclear Medicine, 2024
2024
Análisis radiómico PET intra y peritumoral para predecir la respuesta patológica en pacientes con cáncer de mama que reciben quimioterapia neoadyuvante
A Aksu, ZG Güç, KA Küçüker, A Alacacıoğlu, B Turgut
Revista Española de Medicina Nuclear e Imagen Molecular 43 (3), 500002, 2024
2024
Intra and peritumoral PET radiomics analysis to predict the pathological response in breast cancer patients receiving neoadjuvant chemotherapy
A Aksu, ZG Güç, KA Küçüker, A Alacacıoğlu, B Turgut
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 43 …, 2024
2024
A different perspective on PET/CT before treatment in patients with Hodgkin lymphoma: importance of volumetric and dissemination parameters
A Aksu, KA Küçüker, Ş Solmaz, B Turgut
Annals of Hematology 103 (3), 813-822, 2024
2024
Una perspectiva diferente sobre la radiómica con 18F-FDG-PET en pacientes con cáncer colorrectal; la relación entre el análisis intra y peritumoral y los hallazgos patológicos
ÖV Topuz, A Aksu, MBY Özgüven
Revista Española de Medicina Nuclear e Imagen Molecular 42 (6), 359-366, 2023
2023
A different perspective on 18F-FDG PET radiomics in colorectal cancer patients: The relationship between intra & peritumoral analysis and pathological findings
ÖV Topuz, A Aksu, MBY Özgüven
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 42 …, 2023
2023
Machine learning approach using 18F-FDG PET-based radiomics in differentiation of lung adenocarcinoma with bronchoalveolar distribution and infection
N Agüloğlu, A Aksu, DS Unat
Nuclear Medicine Communications 44 (4), 302-308, 2023
12023
Evaluación de la supervivencia de los pacientes con cáncer de recto metastásico mediante parámetros radiómicos y volumétricos de la PET/TC con [18F] FDG de estadificación
N Agüloğlu, A Aksu
Revista Española de Medicina Nuclear e Imagen Molecular 42 (2), 122-128, 2023
2023
Evaluation of survival of the patients with metastatic rectal cancer by staging 18F-FDG PET/CT radiomic and volumetric parameters
N Agüloğlu, A Aksu
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 42 …, 2023
32023
Evaluation of Tumor Burden Response to Single-cycle of Lu-177 PSMA Treatment with Whole Body Scintigraphic Planar Images in Prostate Cancer Patients
E Acar, A Aksu, EB Ellidokuz, Y Başbınar, GÇ Kaya
Journal of Basic and Clinical Health Sciences 7 (1), 471-478, 2023
2023
The prognostic relationship of 18F-FDG PET/CT metabolic and volumetric parameters in metastatic ALK+ NSCLC
N Agüloğlu, A Aksu, DS Unat, M Akyol
Nuclear Medicine Communications 43 (12), 1217-1224, 2022
2022
Importance of pretreatment 18F-FDG PET/CT texture analysis in predicting Egfr and Alk mutation in Patients with non-small cell lung cancer
N Agüloğlu, A Aksu, M Akyol, N Katgı, TÇ Doksöz
Nuklearmedizin-NuclearMedicine 61 (06), 433-439, 2022
52022
Volumetric Evaluation of Staging 18F-FDG PET/CT Images in Patients with Esophageal Cancer
NPK Şen, A Aksu, GÇ Kaya
Molecular Imaging and Radionuclide Therapy 31 (3), 216, 2022
12022
Tracheitis diagnosed with 68Ga-PSMA PET/CT in a patient with COVID-19
A Aksu, K Bozkurt, B Yılmaz
Clinical Nuclear Medicine 47 (10), e656-e657, 2022
42022
Adult tiger man: a case of dermatomyositis associated with thymoma
A Aksu, C Şin, B Yilmaz
Clinical Nuclear Medicine 47 (6), e448-e449, 2022
22022
Prediction of early biochemical response after 177Lu-PSMA radioligand therapy with 68Ga-PSMA PET, a different perspective with quantitative parameters
A Aksu, ÖV Topuz, B Yilmaz, NPK Şen, E Acar, GÇ Kaya
Nuclear Medicine Communications 43 (4), 468-474, 2022
12022
The Evaluation of Preoperative 18F-FDG PET/CT in Patients with Endometrial Cancer and the Correlation Between PET Parameters and Postoperative Pathology Results
ÖV Topuz, A Aksu, SR Erinç, N Tokgözoğlu, MÖ Tamam
Molecular Imaging and Radionuclide Therapy 31 (1), 16, 2022
32022
Dual time point imaging of staging PSMA PET/CT quantification; spread and radiomic analyses
A Aksu, Ö Vural Topuz, G Yılmaz, G Çapa Kaya, B Yılmaz
Annals of Nuclear Medicine, 1-9, 2022
82022
Interreader agreement in evaluation of 68Ga-PSMA PET/CT at the time of initial staging: comparison of the three evaluation criteria in the pretreatment risk groups
NPK Şen, A Aksu, O Bozkurt, EB Tuna, GÇ Kaya
Nuclear Medicine Communications 43 (1), 86-91, 2022
12022
Is SUV Corrected for Lean Body Mass Superior to SUV of Body Weight in 68Ga-PSMA PET/CT?
A Aksu, GÇ Kaya
Molecular Imaging and Radionuclide Therapy 30 (3), 144, 2021
22021
系统目前无法执行此操作,请稍后再试。
文章 1–20